Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 395-401

  Zagami, Rose Maria ^a   Di Pino, Antonino ^a   Urbano, Francesca ^a   Piro, Salvatore ^a   Purrello, Francesco ^a   Rabuazzo, Agata Maria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Arterial stiffness; HbA1c; Intima media thickness; Pre diabetes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; VITAMIN D;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PREDIABETIC STATE; PREDICTIVE VALUE; PULSE WAVE; REGRESSION ANALYSIS; VITAMIN D DEFICIENCY;

ADULT; BIOMARKERS; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84946211456     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.038     Document Type: Article

References (43)

1. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
2. Shankar A., Sabanayagam C., Kalidindi S. Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diabetes Care 2011, 34:1114-1119.
3. Di Pino A., Scicali R., Calanna S., et al. Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American diabetes association criteria. Diabetes Care 2014, 37:1447-1453.
4. Kendrick J., Targher G., Smits G., et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 2009, 205:255-260.
5. Robinson-Cohen C., Hoofnagle A.N., Ix J.H., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. Jama 2013, 310:179-188.
6. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
7. Xiang W., Kong J., Chen S., et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E125-E132.
8. Brandenburg V.M., Vervloet M.G., Marx N. The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 2012, 225:253-263.
9. Chowdhury R., Kunutsor S., Vitezova A., et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348:g1903.
10. Cigolini M., Iagulli M.P., Miconi V., et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006, 29:722-724.
11. Veronese N., Rui M., Bolzetta F., et al. Serum 25-hydroxyvitamin D and the incidence of peripheral artery disease in the elderly: the Pro.V.A Study. J. Atheroscler. Thromb. 2015, 22(7):726-734.
12. Veronese N., Sergi G., De Rui M., et al. Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. Study. J. Clin. Endocrinol. Metab. 2014, 99:2351-2358.
13. Calanna S., Piro S., Di Pino A., et al. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. Obesity 2013, 21:320-325.
14. Calanna S., Urbano F., Piro S., et al. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 2012, 166:917-922.
15. Mosca A., et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin. Chem. Lab. Med. CCLM/FESCC 2007, 45:1077-1080. International Federation of Clinical, C, Laboratory Medicine, ISDISD.
16. Di Pino A., Alagona C., Piro S., et al. Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. Atherosclerosis 2012, 223:458-462.
17. de las Heras J., Rajakumar K., Lee S., et al. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care 2013, 36:2048-2053.
18. Pan Y., Jackson R.T. Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males. Epidemiol. Infect. 2008, 136:421-431.
19. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
20. Lee J.I., Oh S.J., Ha W.C., et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res. Clin. Pract. 2012, 95:42-47.
21. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. 2006, 65:593-597.
22. Lieberman R., Wadwa R.P., Nguyen N., et al. The association between vitamin D and vascular stiffness in adolescents with and without type 1 diabetes,. PloS One 2013, 8:e77272.
23. van Dijk S.C., Sohl E., Oudshoorn C., et al. Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population. Age Ageing 2015, 44:136-142.
24. Sabio J.M., Vargas-Hitos J.A., Martinez-Bordonado J., et al. Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. Lupus 2015, 24:155-163.
25. Blondon M., Sachs M., Hoofnagle A.N., et al. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2639-2645.
26. Choi H.S., Kim S.H., Rhee Y., et al. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int. J. Clin. Pract. 2008, 62:1352-1357.
27. Michos E.D., Streeten E.A., Ryan K.A., et al. Serum 25-hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the Old Order Amish. Calcif. Tissue Int. 2009, 84:195-202.
28. Pilz S., Henry R.M.A., Snijder M.B., et al. 25-Hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif. Tissue Int. 2009, 84:423-424.
29. Lim S., Shin H., Kim M.J., et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean longitudinal study on health and aging. J. Clin. Endocr. Metab. 2012, 97:169-178.
30. Sachs M.C., Shoben A., Levin G.P., et al. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the multi-ethnic study of Atherosclerosis. Am. J. Clin. Nutr. 2013, 97:1243-1251.
31. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. 2006, 65:593-597.
32. Choi A.I., Lo J.C., Mulligan K., et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin. Infect. Dis. 2011, 52:941-944.
33. Zoppini G., Galletti A., Targher G., et al. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PloS One 2013, 8:e82733.
34. Bellan M., Guzzaloni G., Rinaldi M., et al. Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc. Diabetol. 2014, 13:57.
35. Kayaniyil S., Vieth R., Retnakaran R., et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010, 33:1379-1381.
36. Forouhi N.G., Luan J., Cooper A., et al. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the medical research council ely prospective study 1990-2000. Diabetes 2008, 57:2619-2625.
37. Bell N.H., Greene A., Epstein S., et al. Evidence for alteration of the vitamin-D-endocrine system in Blacks. J. Clin. Investig. 1985, 76:470-473.
38. Liel Y., Ulmer E., Shary J., et al. Low circulating vitamin-D in obesity. Calcif. Tissue Int. 1988, 43:199-201.
39. Wortsman J., Matsuoka L.Y., Chen T.C., et al. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000, 72:690-693.
40. Clark P., Vivanco-Munoz N., Pina J.T., et al. High prevalence of hypovitaminosis D in Mexicans aged 14 years and older and its correlation with parathyroid hormone. Arch. Osteoporos. 2015, 10:225.
41. George P.S., Pearson E.R., Witham M.D. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. J. Br. Diabet. Assoc. 2012, 29:e142-150.
42. Tabesh M., Azadbakht L., Faghihimani E., et al. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 2014, 57:2038-2047.
43. Davidson M.B., Duran P., Lee M.L., et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013, 36:260-266.